L-R: Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford

18 June 2024FeaturesEuropeAnna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford

Life sciences cases at the UPC will surely rise, but is the court prepared?

Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Pfizer, Moderna vow appeals after split vaccine ruling

Carpmaels & Ransford expands life sciences partnership

Unified Patent Court: The cases, the numbers and what the future holds

Second chances: Brazil’s bid to revitalise the country’s healthcare system

High Court says disclosure ‘last resort’ for patent cases in stoma bag dispute

Why the US non-competes ban has riled Big Pharma

Federal Circuit overturns ban on EOFlow’s insulin pump patches

Looking back at the UPC’s ‘successful’ first year

Life sciences cases at the UPC will surely rise, but is the court prepared?

Editor's picks

Editor's picks

More features